Patients with colorectal cancer (CRC) have benefited significantly from advances in multimodal treatment with significant improvements in long-term survival. More patients are currently being treated with surgical resection or ablation following neoadjuvant or adjuvant chemotherapy. However. several cytotoxic agents that are administered routinely have been linked to liver toxicities ... https://www.animationbengal.com/